AU1223401A - Porcine b7-1 and antibodies thereto - Google Patents

Porcine b7-1 and antibodies thereto

Info

Publication number
AU1223401A
AU1223401A AU12234/01A AU1223401A AU1223401A AU 1223401 A AU1223401 A AU 1223401A AU 12234/01 A AU12234/01 A AU 12234/01A AU 1223401 A AU1223401 A AU 1223401A AU 1223401 A AU1223401 A AU 1223401A
Authority
AU
Australia
Prior art keywords
porcine
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12234/01A
Inventor
Susan Faas Knight
William L Fodor
Louis A Matis
Russell P Rother
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexion Pharmaceuticals Inc
Original Assignee
Alexion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharmaceuticals Inc filed Critical Alexion Pharmaceuticals Inc
Publication of AU1223401A publication Critical patent/AU1223401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70532B7 molecules, e.g. CD80, CD86
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AU12234/01A 1999-10-22 2000-10-21 Porcine b7-1 and antibodies thereto Abandoned AU1223401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16114099P 1999-10-22 1999-10-22
US60161140 1999-10-22
PCT/US2000/029155 WO2001030377A1 (en) 1999-10-22 2000-10-21 Porcine b7-1 and antibodies thereto

Publications (1)

Publication Number Publication Date
AU1223401A true AU1223401A (en) 2001-05-08

Family

ID=22579983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12234/01A Abandoned AU1223401A (en) 1999-10-22 2000-10-21 Porcine b7-1 and antibodies thereto

Country Status (4)

Country Link
EP (1) EP1140146A4 (en)
AU (1) AU1223401A (en)
CA (1) CA2361637A1 (en)
WO (1) WO2001030377A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11260027B2 (en) 2015-07-29 2022-03-01 Musc Foundation For Research Development Donor organ pre-treatment formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747034A (en) * 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
US5759550A (en) * 1993-05-06 1998-06-02 Pharmagenesis, Inc. Method for suppressing xenograft rejection
US6852847B1 (en) * 1998-03-19 2005-02-08 Heska Corporation Canine and feline B7-2 nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
EP1140146A4 (en) 2004-10-13
EP1140146A1 (en) 2001-10-10
WO2001030377A1 (en) 2001-05-03
CA2361637A1 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
AU1290001A (en) Antibodies
IL223047A (en) Antibody comprising an fc region and uses thereof
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU4935000A (en) Antibodies
AU6058500A (en) Fusion protein and uses thereof
AU3731600A (en) Composition and structures made therefrom
AU5020400A (en) Heteroaryloxypyrimidine insecticides and acaricides
AU1951201A (en) Peptide antigens
GB9927332D0 (en) Novel antibody and uses thereof
AU5441000A (en) Human monoclonal antibody
AU6232300A (en) Receptors and associated proteins
AUPQ342599A0 (en) Conjugates and uses thereof
AU1083501A (en) Antibiotic-metal complex and methods
AU4818600A (en) Ionomeric particulate composition
AU3923000A (en) Agp-1 fusion protein compositions and methods
AU7881800A (en) Epicyclic stage
AU3818400A (en) Bonding agents for silicone materials
AU5706000A (en) Useful polypeptide
AU2452301A (en) Protein methylarginine-specific antibodies
AU3357700A (en) Phenoxypyrimidine insecticides and acaricides
AU3890200A (en) Novel porcine protein and uses thereof
AU2136401A (en) P450rai-2 and related proteins
AU1223401A (en) Porcine b7-1 and antibodies thereto
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU5979300A (en) Angiopoietin-6 and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase